Modern Diagnostic SME IPO
Alloted
Modern Diagnostic & Research Centre Limited (MDRC), established in 1985, is a prominent diagnostic services network in India. The company provides a comprehensive range of pathology and radiology solutions, including high-end molecular diagnostics, 3-Tesla MRI, and 128-slice CT scans. Operating 21 centers across 8 states, MDRC leverages a hub-and-spoke model and a centralized IT platform to offer digital reports and home sample collection. It serves a diverse clientele of individual patients, hospitals, and institutional customers.
Issue Price
90
Current GMP
₹14 (15.56%)
Overall Subscription
376.97x
Issue Size
₹35.04 Cr
Advertisement
Live Subscription by Application
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 489 | 109 | 0.22x |
FII | - | 25 | - |
DFI | - | 3 | - |
MF | - | 0 | - |
Other | - | 81 | - |
| NII | 122 | 43,520 | 356.72x |
bNII | 81 | 28,729 | 354.68x |
Corporate | - | 319 | - |
Individual | - | 28,076 | - |
Other | - | 334 | - |
sNII | 41 | 14,791 | 360.76x |
Corporate | - | 80 | - |
Individual | - | 14,583 | - |
Other | - | 128 | - |
| IND | 426 | 1,45,889 | 342.46x |
Fixed price | - | 1,45,889 | - |
| Total | 1,037 | 1,89,518 | 182.76x |
Live Subscription by Shares
| Category | Shares Offered | Shares Applied | Subscription |
|---|---|---|---|
| QIB | 7.82 L | 15.14 Cr | 193.51x |
FII | - | 3.08 Cr | - |
DFI | - | 41.78 L | - |
MF | - | 0 | - |
Other | - | 11.64 Cr | - |
| NII | 5.86 L | 41.13 Cr | 702.43x |
bNII | 3.90 L | 33.71 Cr | 863.37x |
Corporate | - | 39.22 L | - |
Individual | - | 32.93 Cr | - |
Other | - | 38.21 L | - |
sNII | 1.95 L | 7.43 Cr | 380.57x |
Corporate | - | 3.89 L | - |
Individual | - | 7.33 Cr | - |
Other | - | 6.26 L | - |
| IND | 13.63 L | 46.68 Cr | 342.46x |
Fixed price | - | 46.68 Cr | - |
| Total | 27.31 L | 102.96 Cr | 376.97x |
Subscription Summary
QIB
Shares Applied:193.51x
Applications Offered:0.22x
NII
Shares Applied:702.43x
Applications Offered:356.72x
IND
Shares Applied:342.46x
Applications Offered:342.46x
Quick Stats
Total Categories3
IPO TypeSME
StatusAllotment Out
Join us on Telegram for instant IPO updates!
Join NowData Last Updated
5 Jan 2026, 01:27 pm
Auto-refreshing
Advertisement
Understanding Subscription Categories
QIB
Qualified Institutional Buyers
Includes FII, DFI, Mutual Funds, and other qualified institutions.
NII
Non-Institutional Investors
High net-worth individuals: bNII (₹10L+) and sNII (₹2L-₹10L).
IND
Individual Investors
Individual investors in SME IPOs up to ₹2 lakh.
Frequently Asked Questions
What is the current subscription status of Modern Diagnostic SME?
The current overall subscription for Modern Diagnostic SME is 376.97x. This indicates the total demand relative to the shares offered. Higher subscription typically suggests strong investor interest.
How to check Modern Diagnostic SME subscription status?
You can check Modern Diagnostic SME subscription status on IPOwiz, BSE website, NSE website, or your broker's platform. Subscription data is updated regularly during the IPO period from 31 December 2025 to 2 January 2026.
What do subscription numbers mean?
Subscription numbers show how many times the IPO is oversubscribed. For example, 376.97x means the IPO received 376.97x times more applications than shares available. Higher subscription in retail category generally means lower allotment chances.
When does Modern Diagnostic SME subscription close?
The subscription for Modern Diagnostic SME closes on 2 January 2026. Applications must be submitted before the closing time on this date. Late applications will not be accepted.
What is the difference between QIB, NII, and Individual (IND) subscription?
QIB (Qualified Institutional Buyers) includes mutual funds, FIIs, and other institutions. NII (Non-Institutional Investors) includes high net-worth individuals investing above ₹2 lakh. Individual (IND) includes individual investors with applications up to ₹2 lakh. Each category has separate subscription quotas.
How does subscription affect allotment chances?
Higher subscription in your category means lower allotment chances. For example, if retail subscription is 376.97x, it means there are 376.97x times more applications than shares available, making allotment competitive.
When will Modern Diagnostic SME allotment be finalized?
The allotment for Modern Diagnostic SME will be finalized and announced on 5 January 2026. You can check your allotment status on the registrar's website, BSE, NSE, or your demat account after this date.
What happens after subscription closes?
After subscription closes on 2 January 2026, the company and registrar process all applications. Allotment is finalized by 5 January 2026, and shares are credited to successful applicants' demat accounts before the listing date on 7 January 2026.
Can I apply after subscription closes?
No, you cannot apply after the subscription closes on 2 January 2026. All IPO applications must be submitted during the subscription period from 31 December 2025 to 2 January 2026. Late applications are automatically rejected.
What is the issue size and lot size for Modern Diagnostic SME?
The issue size for Modern Diagnostic SME is ₹35.04 Cr, and the lot size is 1600 shares. The price range is ₹85.0 - ₹90.0. You must apply in multiples of the lot size.